Skip to main content
. 2022 Oct 13;13:893480. doi: 10.3389/fneur.2022.893480

Table 1.

Characteristics of the 71 patients in this series.

Sex (n, %)
Male 14 (19.7%)
Female 57 (80.3%)
Age in years (mean ± SD, range) 52.3 ± 11.2 (31–85)
Primary or postoperative treatment (n, %)
Primary 43 (60.6%)
Postoperative 28 (39.4%)
Initial tumor volume (n, %)
<8 cc 29 (40.8%)
8–20 cc 28 (39.4%)
>20 cc 14 (19.7%)
Tumor location (n, %)
Skull base 59 (83.1%)
Parasagittal sinus 9 (12.7%)
Lateral ventricle 1(1.4%)
Pineal region 1(1.4%)
Tentorium 1(1.4%)
Interval in months between radiosurgery stages
(mean ± SD, range)
6.1 ± 1.9 (3–12)
Peripheral dose (Gy) for first treatment
(mean ± SD, range)
9.0 ± 0.9 (8–13.5)
Peripheral dose (Gy) for second treatment
(mean ± SD, range)
8.6 ± 0.7 (7–10)